{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:21:19Z","timestamp":1758399679583,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"DOI":"10.1038\/hgv.2014.25","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T11:12:20Z","timestamp":1416481940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Osteogenesis imperfecta IIC caused by a novel heterozygous mutation in the C-propeptide region of COL1A1"],"prefix":"10.1038","volume":"1","author":[{"given":"Masaki","family":"Takagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"BFhgv201425_CR1","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1210\/jc.2013-1505","volume":"98","author":"JC Marini","year":"2013","unstructured":"Marini JC, Blissett AR . New genes in bone development: what's new in osteogenesis imperfecta. J Clin Endocrinol Metab 2013; 98: 3095\u20133103.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhgv201425_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM . Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101\u2013116.","journal-title":"J Med Genet"},{"key":"BFhgv201425_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ajmg.1320170205","volume":"17","author":"J Spranger","year":"1984","unstructured":"Spranger J . Osteogenesis imperfecta: a pasture for splitters and lumpers. (Editorial). Am J Med Genet 1984; 17: 425\u2013428.","journal-title":"Am J Med Genet"},{"key":"BFhgv201425_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/jmg.24.7.390","volume":"24","author":"EM Thompson","year":"1987","unstructured":"Thompson EM, Young ID, Hall CM, Pembrey ME . Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta. J Med Genet 1987; 24: 390\u2013405.","journal-title":"J Med Genet"},{"key":"BFhgv201425_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/15513818809042968","volume":"8","author":"HJ van der Harten","year":"1988","unstructured":"van der Harten HJ, Brons JT, Dijkstra PF, Meijer CJ, van Geijn HP, Arts NF et al. Perinatal lethal osteogenesis imperfecta: radiologic and pathologic evaluation of seven prenatally diagnosed cases. Pediatr Pathol 1988; 8: 233\u2013252.","journal-title":"Pediatr Pathol"},{"key":"BFhgv201425_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ajmg.1320170204","volume":"17","author":"DO Sillence","year":"1984","unstructured":"Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL . Osteogenesis imperfecta type II: delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet 1984; 17: 407\u2013423.","journal-title":"Am J Med Genet"},{"key":"BFhgv201425_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jmg.39.1.23","volume":"39","author":"JM Pace","year":"2002","unstructured":"Pace JM, Chitayat D, Atkinson M, Wilcox WR, Schwarte U, Byers PH . A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the pro\u03b11(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases. J Med Genet 2002; 39: 23\u201329.","journal-title":"J Med Genet"},{"key":"BFhgv201425_CR8","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/ajmg.a.34152","volume":"155","author":"M Takagi","year":"2011","unstructured":"Takagi M, Hori N, Chinen Y, Kurosawa K, Tanaka Y, Oku K et al. Heterozygous C-propeptide mutations in COL1A1: osteogenesis imperfecta type IIC and dense bone variant. Am J Med Genet 2011; 155: 2269\u20132273.","journal-title":"Am J Med Genet"},{"key":"BFhgv201425_CR9","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1016\/S0021-9258(17)46833-5","volume":"268","author":"SD Chessler","year":"1993","unstructured":"Chessler SD, Wallis GA, Byers PH . Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. J Biol Chem 1993; 268: 18218\u201318225.","journal-title":"J Biol Chem"},{"key":"BFhgv201425_CR10","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.1074\/jbc.270.15.8642","volume":"270","author":"SR Lamand\u00e9","year":"1995","unstructured":"Lamand\u00e9 SR, Chessler SD, Golub SB, Byers PH, Chan D, Cole WG et al. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly. J Biol Chem 1995; 270: 8642\u20138649.","journal-title":"J Biol Chem"},{"key":"BFhgv201425_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jmg.38.7.443","volume":"38","author":"JM Pace","year":"2001","unstructured":"Pace JM, Kuslich CD, Willing MC, Byers PH . Disruption of one intrachain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta. J Med Genet 2001; 38: 443\u2013449.","journal-title":"J Med Genet"},{"doi-asserted-by":"crossref","unstructured":"Symoens S, Hulmes DJ, Bourhis JM, Coucke PJ, Paepe AD, Malfait F . Type I . Procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure. Hum Mutat 2014; e-pub ahead of print 21 August 2014; 10.1002\/humu.22677.","key":"BFhgv201425_CR12","DOI":"10.1002\/humu.22677"},{"key":"BFhgv201425_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0014-5793(00)01900-1","volume":"479","author":"M Mizuno","year":"2000","unstructured":"Mizuno M, Fujisawa R, Kuboki Y . Carboxyl-terminal propeptide of type I collagen (C-propeptide) modulates the action of TGF-beta on MC3T3-E1 osteoblastic cells. FEBS Lett 2000; 479: 123\u2013126.","journal-title":"FEBS Lett"},{"key":"BFhgv201425_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s002230001150","volume":"67","author":"M Mizuno","year":"2000","unstructured":"Mizuno M, Fujisawa R, Kuboki Y . The effect of carboxyl-terminal propeptide of type I collagen (c-propeptide) on collagen synthesis of preosteoblasts and osteoblasts. Calcif Tissue Int 2000; 67: 391\u2013399.","journal-title":"Calcif Tissue Int"},{"key":"BFhgv201425_CR15","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.hgv.522","author":"Masaki Takagi","year":"2014","unstructured":"Takagi, Masaki HGV Database (2014) http:\/\/dx.doi.org\/10.6084\/m9.figshare.hgv.522"}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hgv201425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hgv201425","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hgv201425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:15:39Z","timestamp":1672964139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hgv201425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,4]]}},"alternative-id":["BFhgv201425"],"URL":"https:\/\/doi.org\/10.1038\/hgv.2014.25","relation":{"references":[{"id-type":"doi","id":"10.6084\/m9.figshare.hgv.522","asserted-by":"subject"}]},"ISSN":["2054-345X"],"issn-type":[{"type":"electronic","value":"2054-345X"}],"subject":[],"published":{"date-parts":[[2014,11,20]]},"assertion":[{"value":"6 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14025"}}